All News #Library
Others
AmMax Bio doses first subjects in Phase IIb trial of TGCT therapy
30 Jan 2023 //
CLINICAL TRIALS ARENA
AmMax Bio Announces Oral Presentation of Phase 2 Data of AMB-05X
18 Nov 2022 //
GLOBENEWSWIRE
AmMax Bio Provides Update on AMB-05X Program for (TGCT)
26 Sep 2022 //
GLOBENEWSWIRE
AmMax Bio Announces Presentation of Phase 2 PK/PD Data of ABM-05X
12 Sep 2022 //
GLOBENEWSWIRE
AmMax Bio Announces AMB-05X Granted FDA Fast Track Designation
07 Sep 2022 //
GLOBENEWSWIRE
AmMax Bio Appoints Dorothy Nguyen, M.D. as VP of Clinical Development
25 Jul 2022 //
GLOBENEWSWIRE

Market Place
Sourcing Support